Leadership Team

Board of Directors

Recent Resources


December 3, 2020

Canexia Health Co-Founder David Hunstman’s exclusive interview with OncLive

In this exclusive interview, Dr. Huntsman discusses the elements of precision medicine that have contributed to its growth in oncology, some of the setbacks regarding its integration, and areas of research that have the potential to propel precision medicine to the next tier of scientific discovery and application.

Sorry, nothing at the moment.

Sorry, nothing at the moment.

Empowering Laboratories. Transforming Care

Our precision oncology solutions digitize biologic samples and make high-quality genomic information accessible and affordable. Discover our platforms for plasma and tissue profiling.

Explore Our Solutions